PAPER Fang Y, Shao A, Huang L, Zhang X, Hermann DM

Editorial: Crosstalk between peripheral and local immune response in the pathophysiology of stroke and neurodegeneration diseases, volume II.

Front Cell Neurosci. 2024;18:1384276. Epub 2024 Feb 28 PubMed.

PAPER Nguyen HV, Mital S, Knopman DS, Alexander GC

Cost-Effectiveness of Lecanemab for Individuals With Early-Stage Alzheimer Disease.

Neurology. 2024 Apr 9;102(7):e209218. Epub 2024 Mar 14 PubMed.

PAPER Abayomi SN, Sritharan P, Yan E, Saripella A, Alhamdah Y, Englesakis M, Tartaglia MC, He D, Chung F

The diagnostic accuracy of the Mini-Cog screening tool for the detection of cognitive impairment-A systematic review and meta-analysis.

PLoS One. 2024;19(3):e0298686. Epub 2024 Mar 14 PubMed.

PAPER Nadeau SE

Lecanemab Questions.

Neurology. 2024 Apr 9;102(7):e209320. Epub 2024 Mar 14 PubMed.

PAPER Skeens A, Siriwardhana C, Massinople SE, Wunder MM, Ellis ZL, Keith KM, Girman T, Frey SL, Legleiter J

The polyglutamine domain is the primary driver of seeding in huntingtin aggregation.

PLoS One. 2024;19(3):e0298323. Epub 2024 Mar 14 PubMed.

PAPER Shahid SS, Dzemidzic M, Butch ER, Jarvis EE, Snyder SE, Wu YC

Estimating the synaptic density deficit in Alzheimer's disease using multi-contrast CEST imaging.

PLoS One. 2024;19(3):e0299961. Epub 2024 Mar 14 PubMed.

PAPER Perera A, Brock O, Ahmed A, Shaw C, Ashkan K

Taking the knife to neurodegeneration: a review of surgical gene therapy delivery to the CNS.

Acta Neurochir (Wien). 2024 Mar 14;166(1):136. PubMed.

PAPER Giannini LA, Boers RG, van der Ende EL, Poos JM, Jiskoot LC, Boers JB, van IJcken WF, Dopper EG, Pijnenburg YA, Seelaar H, Meeter LH, van Rooij JG, Scheper W, Gribnau J, van Swieten JC

Distinctive cell-free DNA methylation characterizes presymptomatic genetic frontotemporal dementia.

Ann Clin Transl Neurol. 2024 Mar;11(3):744-756. Epub 2024 Mar 13 PubMed.

PAPER Bosbach C, Gatzemeier LM, Bloch von Blottnitz KI, König A, Diederichsen U, Steinem C, Outeiro TF

Chemical synthesis of site-selective advanced glycation end products in α-synuclein and its fragments.

Org Biomol Chem. 2024 Mar 27;22(13):2670-2676. PubMed.

PAPER Zhang Z

Q&A with Zhentao Zhang.

Cell Rep. 2024 Mar 26;43(3):113969. Epub 2024 Mar 13 PubMed.

PAPER Shen YX, Lee PS, Teng MC, Huang JH, Wang CC, Fan HF

Influence of Cigarette Aerosol in Alpha-Synuclein Oligomerization and Cell Viability in SH-SY5Y: Implications for Parkinson's Disease.

ACS Chem Neurosci. 2024 Apr 3;15(7):1484-1500. Epub 2024 Mar 14 PubMed.

PAPER Peruzzotti-Jametti L, Willis CM, Krzak G, Hamel R, Pirvan L, Ionescu RB, Reisz JA, Prag HA, Garcia-Segura ME, Wu V, Xiang Y, Barlas B, Casey AM, van den Bosch AM, Nicaise AM, Roth L, Bates GR, Huang H, Prasad P, Vincent AE, Frezza C, Viscomi C, Balmus G, Takats Z, Marioni JC, D'Alessandro A, Murphy MP, Mohorianu I, Pluchino S

Mitochondrial complex I activity in microglia sustains neuroinflammation.

Nature. 2024 Apr;628(8006):195-203. Epub 2024 Mar 13 PubMed.

PAPER Shao Z, Lu Y, Xing A, He X, Xie H, Hu M

Effect of outer membrane vesicles of Lactobacillus pentosus on Tau phosphorylation and CDK5-Calpain pathway in mice.

Exp Gerontol. 2024 May;189:112400. Epub 2024 Mar 15 PubMed.

PAPER Italia M, Salvadè M, La Greca F, Zianni E, Pelucchi S, Spinola A, Ferrari E, Archetti S, Alberici A, Benussi A, Solje E, Haapasalo A, Hoffmann D, Katisko K, Krüger J, Facchinetti R, Scuderi C, Padovani A, DiLuca M, Scheggia D, Borroni B, Gardoni F

Anti-GluA3 autoantibodies define a new sub-population of frontotemporal lobar degeneration patients with distinct neuropathological features.

Brain Behav Immun. 2024 May;118:380-397. Epub 2024 Mar 12 PubMed.

PAPER Zelek WM, Bevan RJ, Morgan BP

Targeting terminal pathway reduces brain complement activation, amyloid load and synapse loss, and improves cognition in a mouse model of dementia.

Brain Behav Immun. 2024 May;118:355-363. Epub 2024 Mar 12 PubMed.